Ophthalmology

High-tech eye drop research targets corneal damage

New research has laid the groundwork for a long-lasting eye drop to treat corneal neovascularisation (CoNV), a condition which affects more than a million people globally each year.

Ophthalmology

New eye drops may prevent a common cause of blindness

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.

Oncology & Cancer

From eye drops to potential leukaemia treatment

An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University ...

page 1 from 9